Cells (Oct 2023)

Aurora Kinase A Regulates Cell Transitions in Glucocorticoid-Induced Bone Loss

  • Xiaojing Qiao,
  • Yang Yang,
  • Yan Zhao,
  • Xiuju Wu,
  • Li Zhang,
  • Xinjiang Cai,
  • Jaden Ji,
  • Kristina I. Boström,
  • Yucheng Yao

DOI
https://doi.org/10.3390/cells12202434
Journal volume & issue
Vol. 12, no. 20
p. 2434

Abstract

Read online

Glucocorticoid-induced bone loss is a severe and toxic effect of long-term therapy with glucocorticoids, which are currently prescribed for millions of people worldwide. Previous studies have uncovered that glucocorticoids reciprocally converted osteoblast lineage cells into endothelial-like cells to cause bone loss and showed that the modulations of Foxc2 and Osterix were the causative factors that drove this harmful transition of osteoblast lineage cells. Here, we find that the inhibition of aurora kinase A halts this transition and prevents glucocorticoid-induced bone loss. We find that aurora A interacts with the glucocorticoid receptor and show that this interaction is required for glucocorticoids to modulate Foxc2 and Osterix. Together, we identify a new potential approach to counteracting unwanted transitions of osteoblast lineage cells in glucocorticoid treatment and may provide a novel strategy for ameliorating glucocorticoid-induced bone loss.

Keywords